Insulin Resistance
Conditions
Keywords
Neuromuscular Electrical Stimulation, Glucose Continuous Monitor, Blood Glucose, Obesity, Resting Metabolic rate
Brief summary
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Interventions
Group will receive Electrical Stimulation up to sensory level
DEVICENeuromuscular Electrical Stimulation
Group will receive Electrical Stimulation up to maximum tolerable level
OTHERResistance Training
Group will receive exercise training.
Sponsors
University of Texas, El Paso
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Overweight/Obese (BMI ≥25) * Sedentary Lifestyle: Physical Activity Level<1.4 * Less than 150min/week of structured Exercise
Exclusion criteria
* Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications * Excessive alcohol, drug abuse, smoking * Pregnant Women * Unwilling to adhere to the study Intervention
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glycemic Control | 8 weeks | Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Respiratory Exchange Ratio | 8 Weeks | Respiratory Exchange Ratio will be used to quantify substrate utilization (fats vs carbohydrates) through the use of indirect calorimetry of in vivo gas exchange |
| Amount of lean mass | 8 weeks | Amount of lean mass will be measured by dual energy x-ray absortiometry |
Countries
United States
Contacts
Primary ContactSudip Bajpeyi, PhD
Outcome results
None listed